Home › Overweight
Overweight clinical trials recruiting in the U.S.
204 studies for Overweight are recruiting participants at sites across the United States.
Cities with the most studies
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL27 studies
- Orlando, FL25 studies
- Miami, FL23 studies
- Las Vegas, NV22 studies
- Atlanta, GA21 studies
- Dallas, TX20 studies
- Washington, DC19 studies
- Austin, TX19 studies
- New York City, NY19 studies
- Jacksonville, FL18 studies
- Baltimore, MD17 studies
- Havelock, NC17 studies
- Birmingham, AL17 studies
- Charlotte, NC16 studies
- Concord, CA16 studies
- Cincinnati, OH15 studies
- Phoenix, AZ15 studies
- Tucson, AZ15 studies
- Louisville, KY15 studies
- Johns Creek, GA14 studies
- Los Angeles, CA14 studies
- St. Louis, MO14 studies
- Philadelphia, PA14 studies
- San Diego, CA13 studies
- Boston, MA13 studies
- Columbus, OH13 studies
- Indianapolis, IN13 studies
- Salt Lake City, UT13 studies
- Escondido, CA12 studies
- Greensboro, NC12 studies
- Grand Prairie, TX12 studies
- Honolulu, HI11 studies
- Rochester, NY11 studies
- Arlington, VA11 studies
- South Fulton, GA11 studies
- Wilmington, NC11 studies
- Baton Rouge, LA11 studies
- Nashville, TN10 studies
By state
- Alabama30 studies
- Arizona29 studies
- Arkansas6 studies
- California64 studies
- Colorado12 studies
- Connecticut16 studies
- District of Columbia7 studies
- Florida53 studies
- Georgia37 studies
- Hawaii11 studies
- Idaho19 studies
- Illinois37 studies
- Indiana16 studies
- Iowa9 studies
- Kansas27 studies
- Kentucky21 studies
- Louisiana24 studies
- Maryland37 studies
- Massachusetts25 studies
- Michigan19 studies
- Minnesota12 studies
- Mississippi11 studies
- Missouri32 studies
- Montana6 studies
- Nebraska7 studies
- Nevada23 studies
- New Hampshire4 studies
- New Jersey16 studies
- New Mexico4 studies
- New York45 studies
- North Carolina41 studies
- North Dakota8 studies
- Ohio36 studies
- Oklahoma18 studies
- Oregon13 studies
- Pennsylvania32 studies
- Rhode Island13 studies
- South Carolina34 studies
- South Dakota4 studies
- Tennessee25 studies
- Texas55 studies
- Utah22 studies
- Virginia33 studies
- Washington24 studies
- Wisconsin8 studies
Recently updated studies
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07668414A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07720271Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
RecruitingPhase 2Healthy volunteers welcome
Ages 18 to 60 · Women · Updated Sep 28, 2026 · NCT03407079Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Sep 28, 2026 · NCT07399678Physical and Behavioral Traits of Overweight and Obese Adults
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT00428987Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT07837973Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07752979Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07594093A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937086A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 23, 2026 · NCT07803744FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
Recruiting
Ages 18 to 75 · All sexes · Updated Sep 23, 2026 · NCT06724406A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07369011A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07392190A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07589608CHOICE to AVOID or RESIST
RecruitingHealthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT06521021Impact of Lean Pork on Endothelial Function in Perimenopause
RecruitingHealthy volunteers welcome
Ages 40 to 55 · Women · Updated Sep 22, 2026 · NCT06976112From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.